These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 8349163
1. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor. Manetta A, Emma D, Gamboa G, Liao S, Berman M, DiSaia P. Gynecol Oncol; 1993 Jul; 50(1):38-44. PubMed ID: 8349163 [Abstract] [Full Text] [Related]
2. Effect of recombinant human tumor-necrosis-factor-alpha and dequalinium chloride on human ovarian-cancer cell-lines in-vitro. Manetta A, Emma D, Fuchtner C, Gamboavujicic G, Paredes P, Lucci J, Gatanaga T, Granger G. Int J Oncol; 1993 Jul; 3(1):127-33. PubMed ID: 21573338 [Abstract] [Full Text] [Related]
3. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A, Gamboa G, Nasseri A, Podnos YD, Emma D, Dorion G, Rawlings L, Carpenter PM, Bustamante A, Patel J, Rideout D. Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539 [Abstract] [Full Text] [Related]
4. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Creasey AA, Reynolds MT, Laird W. Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916 [Abstract] [Full Text] [Related]
5. Characterization of a human ovarian carcinoma cell line: UCI 101. Fuchtner C, Emma DA, Manetta A, Gamboa G, Bernstein R, Liao SY. Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692 [Abstract] [Full Text] [Related]
6. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice]. Kong B, Wang W, Liu C, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Jiang S. Zhonghua Yi Xue Za Zhi; 2002 Sep 10; 82(17):1207-10. PubMed ID: 12475412 [Abstract] [Full Text] [Related]
7. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies. Baisch H, Otto U, Klöppel G. Cancer Res; 1990 Oct 01; 50(19):6389-95. PubMed ID: 2400997 [Abstract] [Full Text] [Related]
8. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-r. Watanabe N, Niitsu Y, Yamauchi N, Umeno H, Sone H, Neda H, Urushizaki I. J Biol Response Mod; 1988 Feb 01; 7(1):24-31. PubMed ID: 2453618 [Abstract] [Full Text] [Related]
9. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma]. Song Y, Shen K, Yu JR. Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307 [Abstract] [Full Text] [Related]
10. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]. Song Y, Shen K, He CX. Zhonghua Fu Chan Ke Za Zhi; 2007 Sep 06; 42(9):617-22. PubMed ID: 17983518 [Abstract] [Full Text] [Related]
11. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts. Song K, Cowan KH, Sinha BK. Oncol Res; 1999 Sep 06; 11(3):153-9. PubMed ID: 10527075 [Abstract] [Full Text] [Related]
12. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts. Giavazzi R, Garofalo A, Ferri C, Lucchini V, Bone EA, Chiari S, Brown PD, Nicoletti MI, Taraboletti G. Clin Cancer Res; 1998 Apr 06; 4(4):985-92. PubMed ID: 9563894 [Abstract] [Full Text] [Related]
13. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice. Yasui H, Adachi M, Imai K. Cancer; 2003 Mar 15; 97(6):1412-20. PubMed ID: 12627504 [Abstract] [Full Text] [Related]
14. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase. Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC. Cancer Res; 1998 Dec 15; 58(24):5731-7. PubMed ID: 9865731 [Abstract] [Full Text] [Related]
15. Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograft. Noviello E, Cimoli G, Cosimi A, Allievi E, Galletti P, Parodi S, Russo P. Cytokine; 1996 Apr 15; 8(4):330-3. PubMed ID: 9162224 [Abstract] [Full Text] [Related]
16. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer. Balkwill FR, Ward BG, Moodie E, Fiers W. Cancer Res; 1987 Sep 15; 47(18):4755-8. PubMed ID: 3113722 [Abstract] [Full Text] [Related]
17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR. Clin Cancer Res; 1997 Nov 15; 3(11):2063-74. PubMed ID: 9815598 [Abstract] [Full Text] [Related]
18. Effects of IL-12 on human ovarian tumors engrafted into SCID mice. Silver DF, Hempling RE, Piver MS, Repasky EA. Gynecol Oncol; 1999 Feb 15; 72(2):154-60. PubMed ID: 10021294 [Abstract] [Full Text] [Related]
19. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma]. Song Y, Shen K, Tang PP. Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 15; 42(11):761-4. PubMed ID: 18307904 [Abstract] [Full Text] [Related]